Generation of RNA/DNA Hybrids in Genomic DNA by Transformation using RNA-containing Oligonucleotides
November 24th, 2010
29.4K views
This work shows how to form an RNA/DNA hybrid at the chromosomal level and reveal transfer of genetic information from RNA to genomic DNA in yeast cells.
Overview
This study demonstrates the formation of RNA/DNA hybrids at the chromosomal level in yeast cells, revealing the transfer of genetic information from RNA to genomic DNA.
Key Study Components
Area of Science
- Genetics
- Molecular Biology
- Cell Biology
Background
- RNA/DNA hybrids play a crucial role in genetic information transfer.
- Understanding hybrid stability in vivo can provide insights into genetic processes.
- This research utilizes a yeast model to study gene correction mechanisms.
- The yeast strain used has specific mutations that allow for selective growth on media.
Purpose of Study
- To generate RNA/DNA hybrids in live yeast cells.
- To investigate the correction of mutated genes using RNA templates.
- To assess the stability of RNA embedded in genomic DNA.
Methods Used
- Transformation of yeast cells with RNA-containing oligos.
- Use of selective media to identify successful gene corrections.
- Restriction digestion analysis and sequence analysis to confirm results.
- Alkaline liability assays to assess hybrid stability.
Main Results
- Successful formation of RNA/DNA hybrids in yeast cells.
- Evidence of genetic information transfer from RNA to genomic DNA.
- Quantification of gene correction frequency through colony counts.
- Analysis confirms the stability of RNA/DNA hybrids in vivo.
Conclusions
- This study provides a method for generating RNA/DNA hybrids in yeast.
- Findings enhance understanding of RNA's role in gene correction.
- Results have implications for genetic engineering and therapeutic applications.
Frequently Asked Questions
What is the significance of RNA/DNA hybrids?
RNA/DNA hybrids are important for understanding gene expression and regulation mechanisms.
How does the transformation process work?
Yeast cells are transformed with RNA oligos that correct specific mutations in their genome.
What methods were used to analyze the results?
Restriction digestion, sequence analysis, and alkaline liability assays were employed to confirm gene correction.
What are the implications of this research?
The findings could lead to advancements in genetic engineering and therapeutic strategies for genetic disorders.
How does the yeast model contribute to this research?
Yeast serves as a simple model organism to study complex genetic processes in a controlled environment.
What challenges are associated with RNA/DNA hybrid stability?
Factors such as cellular environment and the presence of nucleases can affect hybrid stability.
Executive Industry Relevance
This method enables targeted investigation of RNA/DNA hybrid formation and stability in living cells, providing a controlled system to assess genetic integrity risks associated with ribonucleotide misincorporation. By quantifying gene correction frequency from RNA templates, it supports mechanistic de-risking of nucleic acid-based therapeutic modalities. The approach offers translational value for evaluating hybrid-mediated mutagenesis in preclinical target validation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of RNA/DNA hybrid consequences on genetic stability and repair pathway activation.
- Operational Value: Provides a quantifiable readout of hybrid formation via selectable marker correction in yeast.
Screening & Assay Development
- Scientific Value: Generates standardized chromosomal hybrids with defined length and composition for reproducible phenotypic screening.
- Operational Value: Utilizes selectable media and colony counting to enable high-throughput assessment of correction frequency.
Translational & Preclinical Research
- Scientific Value: Facilitates cross-species extrapolation from yeast to mammalian systems for hybrid stability profiling.
- Operational Value: Supports preclinical de-risking by linking hybrid persistence to potential genotoxic outcomes.
Pipeline & Workflow Integration
The method fits within early discovery workflows where nucleic acid hybrid formation is evaluated as a mechanism of action or off-target effect, informing lead optimization decisions.
- Discovery Biology: Supports hypothesis testing on whether RNA/DNA hybrids trigger DNA damage responses or mutagenesis.
- Screening: Enables assay-ready systems for quantifying hybrid-mediated gene correction across oligo designs.
- Analytics: Restriction digestion and sequencing provide orthogonal validation of RNA-templated genetic information transfer.
- Translational Research: Connects yeast-based hybrid formation to mammalian cell relevance through conserved nucleic acid metabolism.
- Enterprise Reuse: Establishes a reusable platform for evaluating oligo-induced chromosomal alterations in diverse cell systems.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking of RNA-targeted therapies by assessing hybrid formation and stability.
- Operational Value: Standardized transformation and selection protocol ensures reproducibility across laboratories.
- Strategic Value: Informs go/no-go decisions by quantifying nucleic acid-mediated genetic alteration frequencies.
- Portfolio Impact: Enables risk-adjusted prioritization of oligonucleotide candidates based on hybrid formation potential.
Implementation Considerations
- Requires expertise in yeast transformation and nucleic acid handling under RNase-free conditions.
- Dependent on thermal cyclers, shakers, and restriction enzymes for validation steps.
- Necessitates cross-team standardization of oligo quality control and contamination monitoring.
- Adaptation to mammalian cells may require optimization of delivery and selection strategies.
- Practical limitation: Hybrid detection relies on selectable markers, limiting application to engineered loci.
Biopharma FAQs
Why does null hypothesis testing matter for target validation when assessing RNA/DNA hybrid formation?
Null hypothesis testing determines whether observed gene correction frequencies exceed background levels, ensuring that RNA-templated changes are statistically significant and not due to spontaneous mutation. This supports confident target validation by distinguishing true hybrid-mediated effects from experimental noise.
How does independent variable isolation fit the discovery pipeline when studying RNA-containing oligo effects?
Isolating the RNA-containing oligo as the independent variable allows researchers to attribute gene correction specifically to its RNA tract, distinguishing it from DNA-only controls or contamination. This clarity is essential for early discovery pipelines where mechanistic specificity informs target confidence.
What quantitative dependent variable measurements enable assessment of gene correction frequency in this method?
Colony counts on selective media lacking tryptophan serve as the quantitative dependent variable, reflecting successful gene correction via RNA templating. These counts are normalized to total viable cells to calculate transformation frequency, enabling comparison across oligo treatments.
Why do replication requirements matter for cross-functional collaboration in validating RNA/DNA hybrid formation?
Replication across independent transformations ensures that observed gene correction frequencies are robust and not attributable to batch-specific oligo variability or technical artifacts. This supports reliable data sharing between discovery, assay development, and preclinical teams.
What statistical analysis capabilities are required before implementing this method for lead identification?
The method requires capability to calculate mean and standard error of the mean from triplicate transformation experiments to assess gene correction frequency and its variability. This enables statistical comparison between RNA-containing and DNA-only oligos to confirm RNA-specific effects.
Chapters in this video
0:05
Title
1:53
Preparation of the RNA-containing Oligo and the Yeast Cells for Transformation
1:20
Introduction
7:47
Analysis of Gene Correction by the RNA-Containing Oligo
4:40
Transformation of Yeast Cells Using the RNA-Containing Oligo
11:10
Alkali Treatment of the RNA-Containing Oligo
12:20
Representative Results for Transformation Using RNA-Containing Oligonucleotides
16:10
Conclusion
